Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Frequency ExchangeFRECF 8 Cash-to-Debt is 1.62 as of Mar. 2026, which is 110% above its 10-year median of 0.77. GuruFocus rates FRECF with a GF Score™ of 8/100 and a GF Value™ of $0.08 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 849 Medical Devices & Instruments companies, Frequency Exchange ranks worse than 50.53% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Frequency Exchange's cash to debt ratio for the quarter that ended in Mar. 2026 was 1.62.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Frequency Exchangecould pay off its debt using the cash in hand for the quarter that ended in Mar. 2026.
The historical rank and industry rank for Frequency Exchange's Cash-to-Debt or its related term are showing as below:
FRECF'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.17 Med: 0.77 Max: No Debt
Current: 1.62
During the past 6 years, Frequency Exchange's highest Cash to Debt Ratio was No Debt. The lowest was 0.17. And the median was 0.77.
FRECF's Cash-to-Debt is ranked worse than 50.53% of 849
companies
in the Medical Devices & Instruments industry
Industry Median: 1.64
vs FRECF: 1.62
Frequency Exchange (OTCPK:FRECF) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Frequency Exchange Cash-to-Debt Related Terms
Frequency Exchange Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Frequency Exchange's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Medical Devices subindustry, Frequency Exchange's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Frequency Exchange Cash-to-Debt vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Frequency Exchange's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Frequency Exchange's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Frequency Exchange (FRECF) has a Cash-to-Debt of 1.62 as of Mar. 2026. This is 110% above median its historical median of 0.77. Over the past decade, Frequency Exchange's Cash-to-Debt has ranged from 0.17 to 10,000.00. According to the industry distribution chart, Frequency Exchange ranks #429 out of 849 companies in the Medical Devices & Instruments industry, placing it in the top 50.5%.
Is Frequency Exchange's Cash-to-Debt too high?
Frequency Exchange's current Cash-to-Debt of 1.62 is 110% above median its 10-year median of 0.77. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 10,000.00. The Medical Devices & Instruments industry median Cash-to-Debt is 1.64. Frequency Exchange's value of 1.62 is 1.2% below this industry median. Based on the distribution chart, Frequency Exchange ranks #429 out of 849 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Frequency Exchange has a GF Score™ of 8/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Frequency Exchange's Cash-to-Debt compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Frequency Exchange ranks #429 out of 849 companies for Cash-to-Debt. This places Frequency Exchange in the lower half of its industry. The industry median Cash-to-Debt is 1.64. Frequency Exchange's value of 1.62 is 1.2% below this benchmark. Historically, Frequency Exchange's own Cash-to-Debt has ranged from 0.17 to 10,000.00 over the past decade. While the company's 10-year median is 0.77 vs. the industry median of 1.64, Frequency Exchange has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Medical Devices & Instruments company?
The median Cash-to-Debt among Medical Devices & Instruments companies is 1.64, based on 849 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Frequency Exchange's current Cash-to-Debt of 1.62 is 1.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Cash-to-Debt is 1.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Frequency Exchange's current Cash-to-Debt is 1.62, which is 110% above median its own 10-year median of 0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frequency Exchange stock overvalued right now?
Based on GuruFocus' analysis, Frequency Exchange (FRECF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.08, compared to a current price of $0.20 — trading 146.4% above its estimated fair value. The current Cash-to-Debt is 1.62, which is 110% above median its 10-year median of 0.77 and 1.2% below the Medical Devices & Instruments industry median of 1.64. Frequency Exchange's overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Frequency Exchange (FRECF), the current Cash-to-Debt is 1.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Frequency Exchange (FRECF) Overvalued in 2026?
Based on GuruFocus' analysis, Frequency Exchange stock appears to be overvalued.
The current stock price of $0.20 is trading 146.4% above its estimated GF Value™ of $0.08.
GuruFocus considers Frequency Exchange to be Significantly Overvalued.
Key valuation signals for FRECF:
Cash-to-Debt: 1.62 (110% above median its 10-year median of 0.77)
GF Value™: $0.08 vs. price of $0.20 (146.4% above fair value)
Industry Position: 1.2% below the Medical Devices & Instruments median (#429 of 849)
No single metric tells the full story. See the FRECF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Frequency Exchange Corp is focused on the development and world-wide commercialization of a wearable Frequency Delivery System providing specialized programs designed for health and wellness as well as performance enhancement. The company has one operating and reportable segment which the sale of wearable devices. Geographically, it operates in Canada; United States; and International.
8GF Score
Get the complete analysis for FRECF
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRECF has been successfully added to your 
